Sean A. McCarthy
2019
In 2019, Sean A. McCarthy earned a total compensation of $3.8M as Chief Executive Officer and Chairman of the Board of Directors at CytomX Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $327,750 |
---|---|
Option Awards | $2,862,180 |
Salary | $575,000 |
Other | $5,000 |
Total | $3,769,930 |
McCarthy received $2.9M in option awards, accounting for 76% of the total pay in 2019.
McCarthy also received $327.8K in non-equity incentive plan, $575K in salary and $5K in other compensation.
Rankings
In 2019, Sean A. McCarthy's compensation ranked 3,193rd out of 13,971 executives tracked by ExecPay. In other words, McCarthy earned more than 77.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,193 out of 13,971 | 77th |
Division Manufacturing | 1,152 out of 5,701 | 80th |
Major group Chemicals And Allied Products | 391 out of 2,200 | 82nd |
Industry group Drugs | 321 out of 1,886 | 83rd |
Industry Pharmaceutical Preparations | 237 out of 1,398 | 83rd |
Source: SEC filing on April 27, 2022.
McCarthy's colleagues
We found two more compensation records of executives who worked with Sean A. McCarthy at CytomX Therapeutics in 2019.